Prognostic Evaluation of the Expression of HER-2/neu in Adenocarcinoma of the Uterine Cervix - An Original Study in a Tertiary Care Centre

Abstract

Background: Worldwide, cervical carcinoma is second only to breast carcinoma in its incidence and mortality. About 471,000 new cases are diagnosed every year, mainly among the economically disadvantaged in both developing and industrialized nations. Cancer of uterine cervix, the most prevalent cancers among the Indian females, is an important cause of morbidity and mortality among women . Adenocarcinoma currently comprises 10-25% of all cervical carcinomas. The overall survival rate for adenocarcinoma of cervix is worse than from the more common squamous cell carcinoma of the uterine cervix. Materials and methods: This study was conducted in the Department of Pathology, R.G.Kar Medical College and Hospital. It was cross-sectional observational study ,was done in the Department of Pathology, R.G. Kar Medical College and Hospital, Kolkata. A total of 105 cases of cervical carcinoma cases were obtained during the period of January 2017 to June 2018.Out of 105 cases, 20 cases (19%)of Adenocarcinoma of cervix were diagnosed during this period. After confirming the diagnosis of Adenocarcinoma of Cervix histopathologically, sections were taken for immunohistochemical expression of HER-2/neu . Results were analysed at the end of the study. Results: HER-2/neu expression areas showed brown coloured membrane staining. Samples with Score 0 and 1+ were considered negative and those with scores 2+ and 3+ were considered positive. Out of 20 cases of adenocarcinoma of cervix ,7 cases(35%) show 1+ positivity, 5 cases (25%)show 2+ positivity, 6 cases(30%) show 3+ positivity. We found in our study that out of 20 cases of cervical adenocarcinoma, 11 cases (55%) were HER-2/neu positive , while rest 9 cases were HER-2/neu negative. In our present study, we noticed that intensity of HER-2/neu expression increased in tumour of higher grade ( Mod. Diff.> Well diff.). However, no statistically significant correlation (p=0.198) was established between the grade of Cervical Adenocarcinoma and Expression of HER-2/neu. Increased lymph node metastasis noted in moderately differentiated Adenocarcinoma cases (i.e. poor prognosis). Conclusion: This study shows the importance of continued basic and traditional research on the HER-2/neu receptors in invasive cervical carcinoma cases.The results of the present study indicate that evaluation of HER-2/neu expression may provide additional and independent prognostic information to predict the clinical course of cervical adenocarcinoma.

Authors and Affiliations

Dr. Tripti Das

Keywords

Related Articles

Dr Omar Farooq, Government Medical College, Srinagar, Jammu and Kashmir, India

Wernicke encephalopathy is an acute neurological condition that is caused by the deficiency of micronutrient thiamine. Thiamine is essential part of various metabolic pathway¬¬ (1) • It's deficiency leads to neuronal...

A case report of plasmodium vivax malaria presenting as hemophagocytic syndrome

Malaria is a protozoal disease caused by Plasmodium species and transmitted by the bite of anopheles mosquitoes. It is still a treat in the tropical countries causing more than 1 million deaths every year. P. falciparum...

Shinu Singla, Doctorate of Medicine, Neurology, Sri Aurobindo Medical College & PG Institute, Indore.

Introduction: Acute UGI bleed is defined as bleed occurring proximally to ligament of trietz common emergency presentation accounting for mortality rate of 10%. Worldwide, peptic ulcer disease is the commonest cause. Var...

Clinicoetiological Profile of Patients Presenting With Drug Induced Liver Injury

Introduction: Drug-induced liver injury (DILI) is common worldwide and has a potentially fatal outcome. We present here the clinical characteristics and outcome of patients with drug induced liver injury from our hospita...

Burning Mouth Syndrome- A Review

The term 'burning mouth syndrome' (BMS) refers to a chronic oral burning pain, diagnosed in the absence of any visible mucosal abnormality or other organic disease. The challenge is the initial recognition of the conditi...

Download PDF file
  • EP ID EP516247
  • DOI -
  • Views 103
  • Downloads 0

How To Cite

Dr. Tripti Das (2018). Prognostic Evaluation of the Expression of HER-2/neu in Adenocarcinoma of the Uterine Cervix - An Original Study in a Tertiary Care Centre. International Journal of Medical Science and Innovative Research (IJMSIR), 3(9), 302-308. https://europub.co.uk./articles/-A-516247